Selected research
-
The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cells.
Complementary therapies in medicine
-
Implications for the metabolic fate of oral glutamine supplementation within plasma and erythrocytes of patients with sickle cell disease: A pharmacokinetics study.
Complementary therapies in medicine
-
POU domain factor Brn-3a controls the differentiation and survival of trigeminal neurons by regulating Trk receptor expression.
Development (Cambridge, England)
Where I see patients (2)
Saving future lives
500+ UCSF investigators are researching cures for hundreds of childhood and adult diseases.
